Clinical trial
ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial
NCT03004703 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 16, 2017
- Completion date
- February 10, 2021
- Enrollment
- 200 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.